There are today more than 200 therapeutics targeting ovarian cancer, from early preclinical to marketed drugs. Ovarian Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 119

There are today more than 175 therapeutics targeting pancreatic cancer, from early preclinical to marketed drugs. Pancreatic Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked

There are today no less than 58 therapeutics targeting bladder cancer, from early preclinical to marketed drugs. Bladder Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 3

There are today no less than 190 therapeutics targeting melanoma, from early preclinical to marketed drugs. Melanoma Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to more than 13

There are today more than 90 therapeutics targeting liver cancer, from early preclinical to marketed drugs. Liver Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 67 diffe

There are today more than 125 therapeutics targeting brain cancer, from early preclinical to marketed drugs. Brain Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 75 diff

There are today more than 160 therapeutics targeting renal cancer, from early preclinical to marketed drugs. Renal Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 131 dif

There are today more than 250 therapeutics targeting colorectal cancer, from early preclinical to marketed drugs. Colorectal Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 134

There are today more than 340 therapeutics targeting breast cancer, from early preclinical to marketed drugs. Breast Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 165 d

There are today more than 200 anti-angiogenic/vascular disruptive/vascular targeting agents drugs in oncology, from early preclinical to marketed drugs. Angiogenesis in Oncology: Drug Pipeline Update lists all drugs and gives you a progress analysis

There are today more than 380 protein kinase inhibitors for the treatment of cancer, from early preclinical to marketed drugs. Protein Kinase Inhibitors in Oncology: Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of

There are today more than 335 therapeutics targeting lung cancer, from early preclinical to marketed drugs. Lung Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 169 diffe

There are today more than 235 cancer vaccines, from early preclinical to marketed drugs. Cancer Vaccines Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 91 different targets. Th

There are today more than 180 therapeutics targeting lymphoma, from early preclinical to marketed drugs. Lymphoma Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 103 different t

Today, there are more than 190 companies plus partners developing more than 430 antibody based oncology drugs in more than 770 developmental projects. In all targeting around 50 different cancer indications. The number of antibody targets has increased

There are today more than 850 immunotherapy drugs in oncology, from early preclinical to marketed drugs. Immunotherapy in Oncology: Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked

There are today more than 240 therapeutics targeting leukemia, from early preclinical to marketed drugs. Leukemia Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 132 different t

There are today more than 390 therapeutics targeting hematological cancers, from early preclinical to marketed drugs. Hematological Cancers Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are

There are today more than 240 apoptopic drugs for the treatment of cancer, from early preclinical to marketed drugs. Apoptosis in Oncology: Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are

There are today no less than 280 therapeutics targeting prostate cancer, from early preclinical to marketed drugs. Prostate Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked t